Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1974 Sep;18(1):149–153.

Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay

A J Górski
PMCID: PMC1537965  PMID: 4469226

Abstract

The recognized trend towards the standardization of the leucocyte migration assay prompted the comparison of efficacy of BCG with soluble purified protein derivative (PPD) antigens in this test. Even low BCG concentrations permit high correlations between in vivo and in vitro responses, whilst PPD doses needed to elicit comparable reactions fall within toxic concentrations. BCG-induced inhibition of leucocyte migration is abolished by the protein synthesis inhibitor, cycloheximide.

Full text

PDF
149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendixen G., Egeberg J., Nerup J. The fate of corpuscular antigen in leukocyte migration cultures. Transplant Proc. 1972 Jun;4(2):253–258. [PubMed] [Google Scholar]
  2. Curtis J. E., Hersh E. M. Cellular immunity in man: correlation of leukocyte migration inhibition factor formation and delayed hypersensitivity. Cell Immunol. 1973 Jul;8(1):55–61. doi: 10.1016/0008-8749(73)90092-0. [DOI] [PubMed] [Google Scholar]
  3. Górski A. J., Orlowski T., Pomorski Z., Zelechowska M., Kwiek S. The modification of peripheeral leukocyte-migration test using preincubation with specific antigen. Cell Immunol. 1973 Jul;8(1):162–165. doi: 10.1016/0008-8749(73)90103-2. [DOI] [PubMed] [Google Scholar]
  4. In vitro methods in cell-mediated immunity: a progress report. Cell Immunol. 1973 Mar;6(3):331–347. doi: 10.1016/0008-8749(73)90034-8. [DOI] [PubMed] [Google Scholar]
  5. Lockshin M. D., Waxman J., Jenkins M. W. Mechanism of buffy coat migration inhibition test. Experientia. 1973 Mar 15;29(3):340–341. doi: 10.1007/BF01926517. [DOI] [PubMed] [Google Scholar]
  6. Maini R. N., Roffe L. M., Magrath I. T., Dumonde D. C. Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol. 1973;45(1):308–321. doi: 10.1159/000231048. [DOI] [PubMed] [Google Scholar]
  7. Mitchell C. G., Smith M. G., Golding P. L., Eddleston A. L., Williams R. Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin. Clin Exp Immunol. 1972 Aug;11(4):535–541. [PMC free article] [PubMed] [Google Scholar]
  8. Nilsson B. S., Möller G. Reactivity of human lymphocytes to aggregated and nonaggregated PPD-tuberculin. Cell Immunol. 1972 Dec;5(4):555–560. doi: 10.1016/0008-8749(72)90105-0. [DOI] [PubMed] [Google Scholar]
  9. Rauch H. C., King K. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens. Int Arch Allergy Appl Immunol. 1973;44(6):862–874. doi: 10.1159/000230989. [DOI] [PubMed] [Google Scholar]
  10. Read S. E., Zabriskie J. B. Cellular interactions in the leukocyte migration inhibition system. Transplant Proc. 1972 Jun;4(2):247–252. [PubMed] [Google Scholar]
  11. Salvin S. B., Youngner J. S., Lederer W. H. Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun. 1973 Jan;7(1):68–75. doi: 10.1128/iai.7.1.68-75.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zabriskie J. B., Falk R. E. In vitro reactivity of lymphocytes to particulate and soluble antigens. Nature. 1970 Jun 6;226(5249):943–945. doi: 10.1038/226943a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES